Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1011

1.

Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures.

Furnary AP, Zerr KJ, Grunkemeier GL, Starr A.

Ann Thorac Surg. 1999 Feb;67(2):352-60; discussion 360-2.

PMID:
10197653
2.

Does continuous insulin therapy reduce postoperative supraventricular tachycardia incidence after coronary artery bypass operations in diabetic patients?

Kirdemir P, Yildirim V, Kiris I, Gulmen S, Kuralay E, Ibrisim E, Ozal E.

J Cardiothorac Vasc Anesth. 2008 Jun;22(3):383-7. doi: 10.1053/j.jvca.2007.09.015. Epub 2007 Dec 18.

PMID:
18503925
3.

Glucose control lowers the risk of wound infection in diabetics after open heart operations.

Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A.

Ann Thorac Surg. 1997 Feb;63(2):356-61.

PMID:
9033300
4.

Use of both internal thoracic arteries in diabetic patients increases deep sternal wound infection.

Savage EB, Grab JD, O'Brien SM, Ali A, Okum EJ, Perez-Tamayo RA, Eiferman DS, Peterson ED, Edwards FH, Higgins RS.

Ann Thorac Surg. 2007 Mar;83(3):1002-6.

PMID:
17307448
5.

Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.

Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A.

J Thorac Cardiovasc Surg. 2003 May;125(5):1007-21.

6.

Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy.

Schmeltz LR, DeSantis AJ, Thiyagarajan V, Schmidt K, O'Shea-Mahler E, Johnson D, Henske J, McCarthy PM, Gleason TG, McGee EC, Molitch ME.

Diabetes Care. 2007 Apr;30(4):823-8. Epub 2007 Jan 17.

PMID:
17229943
7.

Superficial and deep sternal wound complications: incidence, risk factors and mortality.

Ridderstolpe L, Gill H, Granfeldt H, Ahlfeldt H, Rutberg H.

Eur J Cardiothorac Surg. 2001 Dec;20(6):1168-75.

PMID:
11717023
8.

Reduction in incidence of deep sternal wound infections: random or real?

Matros E, Aranki SF, Bayer LR, McGurk S, Neuwalder J, Orgill DP.

J Thorac Cardiovasc Surg. 2010 Mar;139(3):680-5. doi: 10.1016/j.jtcvs.2009.10.006. Epub 2009 Dec 16.

9.

Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial.

Subramaniam B, Panzica PJ, Novack V, Mahmood F, Matyal R, Mitchell JD, Sundar E, Bose R, Pomposelli F, Kersten JR, Talmor DS.

Anesthesiology. 2009 May;110(5):970-7. doi: 10.1097/ALN.0b013e3181a1005b.

PMID:
19387173
10.

Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting.

Trick WE, Scheckler WE, Tokars JI, Jones KC, Reppen ML, Smith EM, Jarvis WR.

J Thorac Cardiovasc Surg. 2000 Jan;119(1):108-14.

11.

Continuous intravenous insulin infusion reduces infections in diabetics after CABG.

Sajja LR, Kulshresth P, Yarlagadda RB.

Ann Thorac Surg. 2000 Feb;69(2):667-8. No abstract available.

PMID:
10735737
13.

The diabetic disadvantage: historical outcomes measures in diabetic patients undergoing cardiac surgery -- the pre-intravenous insulin era.

Brown JR, Edwards FH, O'Connor GT, Ross CS, Furnary AP.

Semin Thorac Cardiovasc Surg. 2006 Winter;18(4):281-8.

PMID:
17395023
14.

Deep sternal wound infection: risk factors and outcomes.

Borger MA, Rao V, Weisel RD, Ivanov J, Cohen G, Scully HE, David TE.

Ann Thorac Surg. 1998 Apr;65(4):1050-6.

PMID:
9564926
15.

Continuous insulin infusion reduces infectious complications in diabetics following coronary surgery.

Hruska LA, Smith JM, Hendy MP, Fritz VL, McAdams S.

J Card Surg. 2005 Sep-Oct;20(5):403-7.

PMID:
16153268
16.

Sternal wound complications--incidence, microbiology and risk factors.

Ståhle E, Tammelin A, Bergström R, Hambreus A, Nyström SO, Hansson HE.

Eur J Cardiothorac Surg. 1997 Jun;11(6):1146-53.

PMID:
9237601
17.

Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypass grafting at a tertiary care medical center.

Crabtree TD, Codd JE, Fraser VJ, Bailey MS, Olsen MA, Damiano RJ Jr.

Semin Thorac Cardiovasc Surg. 2004 Spring;16(1):53-61.

PMID:
15366688
18.

Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients.

Lazar HL, McDonnell MM, Chipkin S, Fitzgerald C, Bliss C, Cabral H.

Ann Surg. 2011 Sep;254(3):458-63; discussion 463-4. doi: 10.1097/SLA.0b013e31822c5d78.

PMID:
21865944
20.

Prevention of sternal dehiscence and infection in high-risk patients: a prospective randomized multicenter trial.

Schimmer C, Reents W, Berneder S, Eigel P, Sezer O, Scheld H, Sahraoui K, Gansera B, Deppert O, Rubio A, Feyrer R, Sauer C, Elert O, Leyh R.

Ann Thorac Surg. 2008 Dec;86(6):1897-904. doi: 10.1016/j.athoracsur.2008.08.071.

PMID:
19022005

Supplemental Content

Support Center